|Author (Person)||Broberg, Eeva K., Charrel, Remi, Corman, Victor M., Drosten, Christian, Haagmans, Bart, Koopmans, Marion, Leitmeyer, Katrin, Meijer, Adam, Papa, Anna, Reusken, Chantal B. E. M.|
|Publisher||European Centre for Disease Prevention and Control (ECDC)|
|Series Details||Volume 25, Number 6|
|Publication Date||February 2020|
|Content Type||Journal Article|
Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries.
Thirty-eight laboratories in 24 EU/EEA countries had diagnostic tests available by 29 January 2020. A coverage of all EU/EEA countries was expected by mid-February. Availability of primers/probes, positive controls and personnel were main implementation barriers.
|Subject Tags||Diseases, Public Health|
|International Organisations||European Economic Area [EEA], European Union [EU]|